Key facts
- Abacus Insights’s last known valuation is $157.2M.
- It has raised $100.8M across 2 recorded rounds; the latest was Early Stage VC ($6.3M) in Oct 2024.
- Notable investors include CRV, Echo Health Ventures, Escalate Capital Partners, Tech Council Ventures, Flux Ventures — 10 tracked in total.
- Abacus Insights has filed 3 Form Ds with the SEC since 2022, most recently Oct 2024 ($6.3M sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Abacus Insights
Funding rounds
2 roundsAbout Abacus Insights
Developer of a data integration platform designed to harness the healthcare data explosion. The company's platform curates and organizes healthcare data from multiple sources and in different formats while using advanced analytics to have continuous innovation, enabling healthcare companies to generate actionable insights, improve the consumer experience, lower the cost of care, and improve care quality.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2017
- Employees
- 141
- Website
- abacusinsights.com/
- Ownership
- Privately Held (backing)
Abacus Insights doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Abacus Insights shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Abacus Insights in its N-PORT filings yet. We sweep new filings monthly.